:::

詳目顯示

回上一頁
題名:以RU486施行早期人工流產的已婚婦女之決策過程
書刊名:長庚護理
作者:黎小娟陳玉玲
作者(外文):Li, Hsiao-juanChen, Yu-ling
出版日期:2002
卷期:13:2=38
頁次:頁136-145
主題關鍵詞:藥物流產法決策過程現象學研究RU486MifepristoneMedical abortionDecision-making processPhenomenological research
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(3) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:2
  • 共同引用共同引用:0
  • 點閱點閱:20
     藥物流產法是一種安全、有效且接受度高的早期人工流產法,至今全世界已有近三百萬的婦女使用過RU486來進行人工流產。本研究為現象學研究,旨在探討以RU486施行早期人工流產的已婚婦女之決策過程。共訪談了十二位孕婦,以半結構的方式進行訪談,所有訪談的內容均予以錄音,並以Giorgi的現象學方法來分析所收集到的資料。研究結果顯示,其決策過程可分為:震驚期(憂喜參半、難以啟齒)、尋求資訊期(探索媒體資訊、聽取專家意見、尋求經驗談)、猶豫期(道德的衝突、對結果的不確定感、害怕藥物對身體的危害)及做決定期(現實因素的考量、身體的掌控、生育的自主權、重要他人的支持)四個階段。而護理人員經由深入瞭解這些婦女的生活經驗,則可依照個案的需求來設計適當的諮詢或衛教方案。
     Medical abortion is a safe, efficacious, and acceptable method for early abortion. To date, approximately 3 million women worldwide have received RU486 (mifepristone) in regimens for abortion. The main purpose of this phenomenological research was to explore the decision-making processes of married women who requested early abortion with mifepristone. Twelve pregnant women were interviewed and audiotaped using a semi-structured method. Giorgi's qualitative method of phenomenology was used to analyze the data. Results revealed four decision-making stages: shock stage (ambivalence and confidentiality), information-seeking stage (mass media, professionals, and friends' opinions), hesitating stage (moral conflict, uncertainty of results, and fear of medication side effects and risk to body), and decision-making stage (consideration of reality, control of body, conceptual autonomy, and significant persons' support). Thoroughly understanding the lived experiences of these women enables nurses to design appropriate counseling and education programs according to clients' needs.
期刊論文
1.Newhall, E. P.、Winikoff, B.(2000)。Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions。American Journal of Obstetrics & Gynecology,183(2),44-53。  new window
2.Pymar, H. C.、Creinin, M. D.(2001)。Offering mifepristone as an abortion option。Contemporary Obstetrics & Gynecology,46(2),113-120。  new window
3.Aguillaume, C. J.、Tyrer, L. B.(1995)。Current status and future projections on use of RU-486。Contemporary Obstetrics & Gynecology,40(6),23-40。  new window
4.Aubény, H.、Peyron, R.、Turpin, C. L.、Renault, M.、Targosz, V.、Silvestre, L.、Ulmann, A.、Baulieu, E. E.(1995)。Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol。International Journal of Fertility & Menopausal Studies,40(2),85-91。  new window
5.Holmberg, L. I.、Wahlberg, V.(2000)。The process of decision-making on abortion: A grounded theory study of young men in Sweden。Journal of Adolescent Health,26(3),230-234。  new window
6.Simonds, W.、Ellertson, C.、Springer, K.、Winikoff, B.(1998)。Abortion, revised: Participants in the U. S. clinical trials evaluate mifepristone。Social Science & Medicine,46(10),1313-1323。  new window
7.Peyron, R.、Aubeny, E.、Targosz, V.、Silvestre, L.、Renault, M.、Elkik, F.、Leclerc, P.、Ulmann, A.、Baulieu, E. E.(1993)。Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol。New England Journal of Medicine,328(21),1509-1513。  new window
8.Winikoff, B.、Ellertson, C.、Elul, B.、Sivin, I.(1998)。Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol: Results of a large multicenter trial in the United States。Archives of Family Medicine,7(4),360-366。  new window
9.Winikoff, B.、Sivin, I.、Coyaji, K. J.、Cabezas, E.、Bilian, X.、Sujuan, G.(1997)。The acceptability of medical abortion in China, Cuba and India。International Family Planning Perspectives,23(2),73-78。  new window
10.Spitz, I. M.、Bardin, C. W.、Benton, L.、Robbins, A.(1998)。Early pregnancy termination with mifepristone and misoprostol in the United State。New England Journal of Medicine,338(18),1241-1247。  new window
11.陳杏佳(20000800)。現象學方法論與護理研究應用。新臺北護理期刊,2(2),117-123。  延伸查詢new window
12.Dallaire, L.、Lortie, G.、DesRochers, M.、Clermont, R.、Vachon, C.(1995)。Parental reaction and adaptability to the prenatal diagnosis of fetal defect or genetic disease leading to pregnancy interruption。Prenatal Diagnosis,15(3),249-259。  new window
13.Breitbart, V.(2000)。Counseling for medical abortion。American Journal of Obstetrics & Gynecology,183(2),26-33。  new window
14.Bourguignon, A.、Briscoe, B.、Nemzer, L.(1999)。Genetic abortion: considerations for patient care。Journal of Perinatal & Neonatal Nursing,13(2),47-58。  new window
15.Joffe, C.(2000)。Medical abortion in social context。American Journal of Obstetrics & Gynecology,183(2),10-15。  new window
16.Seller, M.、Barnes, C.、Ross, S.、Barhy, T.、Cowmeadow, P.(1993)。Grief and mid-trimester fetal loss。Prenatal Diagnosis,13(5),341-348。  new window
17.Pryde, P.、Isada, N.、Hallak, M.(1992)。Determinants of parental decision to abort or continue after non-aneuploid ultrasound-detected fetal abnormalities。Obstetrics & Gynecology,80(1),52-56。  new window
18.Ngoc, N. T.、Winikoff, B.、Clark, S.、Ellertson, C.、Am, K. N.、Hieu, D. T.(1999)。Safety, efficacy and acceptability of mifepristone- misoprostol abortion in Vietnam。International Family Planning Perspectives,25(1),10-14。  new window
圖書
1.行政院衛生署(1997)。有偶婦女墮胎發生率及發生次數。台北:行政院衛生署。  延伸查詢new window
2.Giorgi, A.(1988)。Phenomenology and psychological research。Pittsburgh, PA:Duquesne University Press。  new window
3.Lincoln, Y. S.、Cuba, E. G.(1985)。Natualistic inquiry。Beverly Hills:Sage。  new window
4.Glaser, B. G.(1978)。Theoretical sensitivity。Mill Valley。  new window
其他
1.台北市政府衛生局第六科(20010827)。人工流產藥物網路意見調查,台北市政府衛生局。,http://www.health.gov.tw/oldnews.asp。  延伸查詢new window
2.台北市女性權益促進會(19990204)。北市成年婦女近半數曾墮胎,時報文教基金會。,http://www.chinatimes.org.tw/news/1999/02/19990204_05.htm。  延伸查詢new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE